Research output: Contribution to journal › Article › peer-review
Valuing synergies in strategic mergers and acquisitions using the real options approach. / Лукьянова, Анна Евгеньевна; Никулин, Егор Дмитриевич; Ведерников, Андрей.
In: Investment Management and Financial Innovations, Vol. 14, No. 1 (continuation), 2017, p. 236-247.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Valuing synergies in strategic mergers and acquisitions using the real options approach
AU - Лукьянова, Анна Евгеньевна
AU - Никулин, Егор Дмитриевич
AU - Ведерников, Андрей
N1 - Loukianova, A. E. Valuing synergies in strategic mergers and acquisitions using the real options approach / A. E. Loukianova, E. D. Nikulin, A. Vedernikov // Investment Management and Financial Innovations. - 2017. - Volume 14, Issue 1. - P. 236-247.
PY - 2017
Y1 - 2017
N2 - The purpose of the current paper is to elaborate the model for assessing cumulative synergetic effect in M&A (Mergers and Acquisitions) deals on the basis of a real options approach. The majority of papers on the synergetic effects of M&A deals typically focus on a particular type of synergy, while the current paper proposes a model that accounts for the cumulative simultaneous effect of different types of operating and financial synergies. The methodology of our research is loosely based on Datar-Mathews real option valuation model, which is flexible and intuitive for practitioners. Formulae for assessing eight types of synergy typically arising from M&A deals are developed. They are integrated into a single model to assess their cumulative effect on the M&A deal using a simulation modelling approach. The method was used ex post to find synergy values in two recent M&A deals in the pharmaceutical industry, and produced sound results. The proposed approach to value target companies could be used by firms before an M&A deal in the due diligence process. Using this tool a company can build a bidding strategy and define the maximum premium it can pay for the target.
AB - The purpose of the current paper is to elaborate the model for assessing cumulative synergetic effect in M&A (Mergers and Acquisitions) deals on the basis of a real options approach. The majority of papers on the synergetic effects of M&A deals typically focus on a particular type of synergy, while the current paper proposes a model that accounts for the cumulative simultaneous effect of different types of operating and financial synergies. The methodology of our research is loosely based on Datar-Mathews real option valuation model, which is flexible and intuitive for practitioners. Formulae for assessing eight types of synergy typically arising from M&A deals are developed. They are integrated into a single model to assess their cumulative effect on the M&A deal using a simulation modelling approach. The method was used ex post to find synergy values in two recent M&A deals in the pharmaceutical industry, and produced sound results. The proposed approach to value target companies could be used by firms before an M&A deal in the due diligence process. Using this tool a company can build a bidding strategy and define the maximum premium it can pay for the target.
KW - mergers
KW - acquisitions
KW - synergy
KW - real options
KW - SCOPUS
KW - РОССИЙСКИЙ ИНДЕКС НАУЧНОГО ЦИТИРОВАНИЯ
KW - SCOPUS
KW - РОССИЙСКИЙ ИНДЕКС НАУЧНОГО ЦИТИРОВАНИЯ
U2 - 10.21511/imfi.14(1-1).2017.10
DO - 10.21511/imfi.14(1-1).2017.10
M3 - Article
VL - 14
SP - 236
EP - 247
JO - Investment Management and Financial Innovations
JF - Investment Management and Financial Innovations
SN - 1810-4967
IS - 1 (continuation)
ER -
ID: 9518060